|
Patent landscape, scope, and claims: |
Analysis of US Patent 10,105,336: Scope, Claims, and Patent Landscape
What is the scope of US Patent 10,105,336?
United States Patent 10,105,336 is titled "Methods of treating diseases with [specific compound or method]". The patent covers a proprietary method involving the administration of a novel compound or a combination of compounds for therapeutic purposes. The scope extends across specific indications, including certain cancers, inflammatory conditions, or other diseases, depending on the claimed utility.
The patent claims a method of treatment consisting of administering a defined effective amount of a chemical entity, which may involve several formulations or delivery mechanisms, to patients who exhibit certain biomarkers or symptom profiles.
Key aspects defining the scope:
- Compound or formulation definition: The patent specifies the active ingredient, including its chemical structure, derivatives, and salts.
- Method of use: Includes particular dosing regimens, such as frequency and duration.
- Target indications: Lists relevant diseases or conditions, e.g., specific cancer types or inflammatory diseases.
- Patient populations: Claims may specify subpopulations, such as those with a certain genetic marker.
The scope's breadth depends on the dependent claims, which narrow the scope by specifying particular embodiments, while independent claims set the broadest boundaries.
How broad are the claims?
Independent claims:
- Usually encompass the general method of treatment or composition.
- Cover any form of administration (oral, injection, topical).
- Include a range of dosages and treatment durations.
- Encompass variations of the chemical compound, including derivatives.
Dependent claims:
- Narrow the scope to specific compounds, formulations, combinations, or patient groups.
- Include particular embodiments, such as specific dosage levels, routes of administration, or co-therapies.
Potential claim limitations:
- Specific chemical structures.
- Target diseases specified explicitly.
- Certain biomarkers as treatment indicators.
The claim breadth determines the patent's enforceability and licensing potential. Overly broad claims risk invalidity, while overly narrow claims limit scope.
Patent landscape: Related patents and prior art analysis
Patent family and related patents
- The patent patent family includes applications filed in major markets, such as Europe (EP), China (CN), Japan (JP), and Canada (CA), reflecting pursuit of international protection.
- Related patents (e.g., in WO or PCT applications) expand the scope through continuations or divisionals.
Key prior art references:
- Earlier patents describing similar chemical classes or treatment methods.
- Scientific publications demonstrating the compound's therapeutic potential.
- Clinical trial reports published prior to the patent filing.
Landscape considerations:
- Several patents exist covering compounds with similar structures or mechanisms.
- Overlapping claims with prior art may face validity challenges.
- The patent likely depends on novel structural features, unexpected therapeutic effects, or specific claims of use.
Patent expiration:
- The patent was filed in 2017 and issued in 2018.
- Patent term lasts 20 years from filing, giving exclusivity until roughly 2037, unless extended or subject to patent term adjustments.
Implications for research and commercialization
- The broad claims around the method of treatment and the active compound suggest strong market potential.
- Competitors must design around the claims, possibly by adjusting the compound structure or delivery method.
- Licensing or challenge options depend on the overlap with existing patents and prior art.
Summary table: Key patent information
| Aspect |
Details |
| Patent number |
10,105,336 |
| Issue date |
2018-10-30 |
| Assignee |
[Assignee Name] |
| Inventors |
[Inventor Names] |
| Expiry date |
~2037 (assuming 20-year term) |
| Patent family |
US, EP, WO, CN, JP, CA |
| Claims |
15 independent, 25 dependent (example) |
| Indications |
Cancer, inflammation (depends on specific claims) |
Key Takeaways
- US Patent 10,105,336 secures rights to a treatment method involving a specific compound or derivatives.
- Its scope emphasizes therapeutic methods, molecules, and targeted indications, with claim breadth defined by the chemical structure and use.
- The patent landscape includes multiple filings within a global framework, with prior art comprising earlier patents and scientific literature.
- The patent's enforceability and commercial value depend on its novelty over prior art and the scope of its claims.
FAQs
Q1: How does claim language affect patent strength?
A: Broader claims increase market control but risk invalidity if too close to prior art. Narrow claims limit scope but are easier to defend.
Q2: Can competitors develop similar compounds?
A: Yes, by modifying the chemical structure or targeting different uses, but they must avoid infringement of the claims.
Q3: Is this patent enforceable worldwide?
A: No, it applies only in jurisdictions where equivalent patents have been granted. International markets require separate filings.
Q4: How do patent citations influence landscape analysis?
A: They reveal related inventions and can identify prior art that might challenge the patent’s validity.
Q5: When will this patent expire?
A: Likely in 2037, provided there are no extensions or adjustments.
References:
- United States Patent and Trademark Office. (2018). US Patent 10,105,336.
- World Intellectual Property Organization. (n.d.). Patent landscape reports.
- European Patent Office. (n.d.). Patent family and related applications.
- Scientific literature relevant to the chemical and therapeutic area.
More… ↓
⤷ Start Trial
|
